Clinical trial
Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC
NCT00443885 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00443885 |
|---|---|
| Title | Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC |
| Official title | Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC to Problematic Gram-negative Organisms |
| Lead sponsor | University of Pittsburgh, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Gram Negative Organism |
| Enrollment | 500 |
| Start date | Feb 1, 2007 |
| Primary completion | Jan 1, 2017 |
| Completion | Jan 1, 2017 |
| First posted | Mar 7, 2007 |
| Last update posted | Jun 12, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: